Sign Up to Receive Your Personalised Learning Resources
Start Learning
FDA accepts NDA for low-dose atropine to slow paediatric myopia progression
What does the future hold for ophthalmology?
FDA approves acoltremon ophthalmic solution for dry eye disease
3 Questions with Dr Laura Maubon: touchOPHTHALMOLOGY Future Leader 2025
Help shape the global picture of paediatric IOL implantation – WSPOS survey still open
Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease
Positive phase II data announced for CBT‑004 in vascularized pinguecula
FDA approves Susvimo (ranibizumab injection) for diabetic retinopathy
AI in oculomics shows potential for non-invasive cardiovascular risk assessment
3 Questions with Dr Jelena Potic: touchOPHTHALMOLOGY Future Leader 2025
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
New study identifies cluster characteristics that predict repeatable visual field defects in early glaucoma
View
OCS-05 shows promise as a novel treatment for acute optic neuritis in Phase 2 ACUITY trial
View
3 Questions with Dr Laura Maubon: touchOPHTHALMOLOGY Future Leader 2025
View
Clinical pearls from WCC IX: Managing zoster keratitis
View
Research highlights from AAO 2024
View
FDA accepts NDA for low-dose atropine to slow paediatric myopia progression
View
5 Questions with Dr Uday Devgan, MD: Leading global education in cataract surgery with CataractCoach.com
View
3 Questions with Dr Alessandro Arrigo: touchOPHTHALMOLOGY Future Leader 2025
View
SOE 2025: A message from the President
View
Foreword: touchREVIEWS in Ophthalmology, Volume 19, Issue 1, 2025
View
